Outline of clinical research: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
No edit summary
 
Line 47: Line 47:
{{stub}}
{{stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 13:04, 18 March 2025

Clinical research is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. Clinical research is different from clinical practice. In clinical practice established treatments are used, while in clinical research evidence is collected to establish a treatment.

Overview[edit]

Clinical research is often conducted at academic medical centers and affiliated research study sites. These centers and sites provide the prestige of the academic institution as well as access to larger metropolitan areas, providing a larger pool of medical participants. These academic medical centers often have their internal Institutional Review Boards that oversee the ethical conduct of medical research.

Types of Clinical Research[edit]

Clinical research can be categorized by the type of study. Studies can be observational (where the researcher observes the patient without intervention), or interventional (where the researcher introduces some sort of intervention, such as a drug or a procedure).

Observational Studies[edit]

In an observational study, the investigators observe the subjects and measure their outcomes. The researchers do not actively manage the study. Instead, they simply observe and gather data.

Interventional Studies[edit]

In an interventional study, the investigators give the research subjects a particular medicine or other intervention. Usually, they compare the treated subjects to subjects who receive no treatment or standard treatment. Then the researchers measure how the subjects' health changes.

Phases of Clinical Trials[edit]

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases I, II, and III, it will usually be approved by the national regulatory authority for use in the general population.

Phase I[edit]

Phase I trials are the first stage of testing in human subjects. Normally, a small (20-80) group of healthy volunteers will be selected. This phase includes trials designed to assess the safety (pharmacovigilance), tolerability, pharmacokinetics, and pharmacodynamics of a drug.

Phase II[edit]

Phase II trials are performed on larger groups (20-300) and are designed to assess how well the drug works, as well as to continue Phase I safety assessments in a larger group of volunteers and patients.

Phase III[edit]

Phase III studies are randomized controlled multicenter trials on large patient groups (300–3,000 or more depending upon the disease/medical condition studied) and are aimed at being the definitive assessment of how effective the drug is, in comparison with current 'gold standard' treatment.

Phase IV[edit]

Phase IV trial is also known as postmarketing surveillance Trial. Phase IV trials involve the safety surveillance (pharmacovigilance) and ongoing technical support of a drug after it receives permission to be sold.

See Also[edit]

References[edit]

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia